Barclays raised the firm’s price target on Crowdstrike to $240 from $225 and keeps an Overweight rating on the shares post the Q3 report. The company’s net new annual recurring revenue returned to growth, growing double digits both organically excluding Bionic and on a reported basis, the analyst tells investors in a research note. The analyst says Crowdstrike’s “platform story will gain steam.”
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CRWD: